Bsenexus Terminal Open in Bsenexus App →
OTHER

Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Solara s Q2 FY27 revenue grows 33% to INR 4,178 Mn and EBITDA more than doubles to INR 769 Mn, its best quarter in five years".

Filing Details / Description
Press Release - Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Solara s Q2 FY27 revenue grows 33% to INR 4,178 Mn and EBITDA more than doubles to INR 769 Mn, its best quarter in five years".
🔗 Related Announcements 5 Disclosures
Lenskart Solutions Ltd OTHER
Lenskart Solutions Ltd - 544600 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Max Healthcare Institute Ltd OTHER
Max Healthcare Institute Ltd - 543220 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Shadowfax Technologies Ltd OTHER
Shadowfax Technologies Ltd - 544685 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
HCL Infosystems Ltd OTHER
HCL Infosystems Ltd - 500179 - Announcement under Regulation 30 (LODR)-Newspaper Publication
RR Securities Ltd OTHER
RR Securities Ltd - 530917 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
📄 View Official BSE Filing (PDF) ↗ Explore Live BSE Corporate Disclosures on Bsenexus →